Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Hazeltine Mark, Chief Executive Officer. Officer active across 1 company, notably EXAGEN INC.. Cumulatively, 6 filings have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €15k. Activity tracked since 17 May 2021. The latest transaction was filed on 2 March 2023 (Cession). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Mark Hazeltine is the Chief Operating Officer at Exagen Inc. He has extensive experience in operational management and corporate strategy. His role allows him to oversee daily operations and ensure process efficiency. Mark is recognized for his leadership and commitment to operational excellence.